188 filings
Page 5 of 10
CORRESP
r6d ykyota
12 Aug 16
Correspondence with SEC
12:00am
8-K
q15jz c67zaqbay1
10 Aug 16
Argos Therapeutics Reports Second Quarter 2016 Financial Results and Recent Operational Highlights
12:00am
CT ORDER
d6eavg m1zeo
8 Aug 16
Confidential treatment order
12:00am
CT ORDER
t95hqoyrhasjwo
8 Aug 16
Confidential treatment order
12:00am
UPLOAD
lrdcscx7g0r34i 2jk4
2 Aug 16
Letter from SEC
12:00am
424B5
o8m60su 2qyil6djbrq
29 Jul 16
Prospectus supplement for primary offering
12:00am
8-K
g67e0
29 Jul 16
Argos Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock and Warrants
12:00am
FWP
sxeomt30
28 Jul 16
Free writing prospectus
12:00am
8-K
105 lb0wuh88
27 Jul 16
Other Events
12:00am
424B5
5u6nr
27 Jul 16
Prospectus supplement for primary offering
12:00am
8-K
v5b hw1lynq5fzh
11 Jul 16
Dr. Richard D. Katz Joins Argos Therapeutics as Chief Financial Officer
12:00am
8-K
4ar44
29 Jun 16
Other Events
12:00am
8-K
bnsx3yt0cn b5
13 Jun 16
Departure of Directors or Certain Officers
12:00am
EFFECT
8k18ushs6ih56td3
26 May 16
Notice of effectiveness
12:00am
CORRESP
k41 ll72ft
25 May 16
Correspondence with SEC
12:00am
CT ORDER
pamrp70d8mesq2 eag
23 May 16
Confidential treatment order
12:00am
UPLOAD
pf2qvcf
20 May 16
Letter from SEC
12:00am
S-8
jp52ai46lvsr45nh5ztq
16 May 16
Registration of securities for employees
12:00am